Anti-Leishmanial Lepidine Derivatives.
DEPARTMENT OF THE ARMY WASHINGTON DC
Pagination or Media Count:
The subject of this patent is 8-6-N-heterocyclic-substitutedhexylamino-6-methoxy lepidine derivatives. These derivatives afford improvement in means for the chemotherapy of leishmaniasis when administered parenterally or orally to infected animals.